Tag: Import Substitution

Pharma market penetration of Russian drugs rose in the 1st half of 2018

Russian drugs penetration into the pharmaceutical market rose in the 1st half of 2018. This was presented to the participants of "Pharma CFO 2018" by Raziya Solodova.

NEARMEDIC launched the first Russian facility for DNA testing reagents production

The full-cycle facility is to manufacture reactants for genetic person’s identification and establishment of filiation through DNA tests.

Moscow Endocrine Plant developed five import-substituting drugs

The Moscow Endocrine Plant, located in the Nizhny Novgorod region, developed five import-substituting drugs under the federal target program 'Pharma-2020'.

First Russian continuous flow hydrogenation reactor will boost drug development

Scientists of Penza State University have developed the continuous flow hydrogenation reactor, which is capable to carry out the entire spectrum of chemical reactions with pure hydrogen.

Kazakh suppliers sidestepped Belarusian colleagues on the Russian pharma market

During the period January-June 2018, medicines produced in the territory of the EAEC countries were imported to Russia for a total of 5.9 billion rubles.

Dalkhimpharm conducts large-scale modernization

A large-scale modernization aimed at expanding production facilities and manufacturing competitive products has began at Dalkhimpharm plant.

Nativa won a patent dispute with Bristol-Myers Squibb with regard to dasatinib

The Arbitration Court of the Moscow region decided to fully reject the claims filed by Bristol-Myers Squibb Holdings Ireland against Nativa LLC under the case No. A41-87845/2017.

Belarus developed the technology of obtaining povidone iodine

Belarus developed a technology for obtaining a pharmaceutical substance that can be used for manufacturing iodine-based medicines, announced Maria Sekach, Commercial Director of Belaseptika CJSC.

First Russian intradermal implant obtained registration

The first Russian intradermal implant has successfully passed the state registration. This product has been developed over the past three years with the support of the Russian Ministry of Industry and Trade.

Titanium Valley resident starts manufacturing of medical devices for neurosurgery

Zibus, a company, launched a production facility to manufacture titanium implants and neurosurgery tools in the Titanium Valley Special Economic Zone (SEZ) located in the Sverdlovsk region.

Prosthetic implants production facility was launched in Rameyev Technopark

In the future, once the enterprise reaches its production capacity, it will employ only local specialists from Penza. The program provides for gradual increase of production capacity over a two-year period.

Participants of Russian industrial clusters will receive subsidies

pharma manufacturing
Pharmaceutical companies participating in an industrial cluster can receive subsidies for up to 50% of their costs incurred for the implementation of joint cluster projects.

Russian drugs displace imports from the market

The first shifts in import substitution and expansion of innovative pharmaceutical production facilities occurred under Pharma - 2020, a state program which started as early as in 2011.

Russian company starts phase 2 clinical trials of its meningococcal vaccine

clinical trials
NPO Microgen has begun phase 2 clinical trials of the first Russian polysaccharide meningococcal vaccine to prevent diseases caused by Neisseria meningitidis serogroups A and C, including meningitis and meningococcemia.

Pharmstandard-Leksredstva will start manufacturing powders for pulmonary delivery

The investment project to manufacture powders for pulmonary drug delivery involving the investment of more than 1.9 billion rubles will continue in 2018.

Manufacturing of nonwoven materials for medicine was launched in Tver region

Hexa – Nonwoven Materials LLC, a borrower of Industry Development Fund (IDF), has launched a new production facility for manufacturing high-tech specialized composite nonwoven materials